EDITORIAL
Published on 30 Aug 2022
Editorial: Chemosensitizing effect of natural products against cancers: Applications in enhancing chemotherapy and immunotherapy
doi 10.3389/fphar.2022.988226
- 1,310 views
- 2 citations
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Chemosensitizing Effect of Natural Products against Cancers: Applications in Enhancing Chemotherapy and Immunotherapy
Chemosensitizing Effect of Natural Products against Cancers: Applications in Enhancing Chemotherapy and Immunotherapy
21k
Total downloads
99k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 20 May 2022
Lumiflavin Reduces Cisplatin Resistance in Cancer Stem-Like Cells of OVCAR-3 Cell Line by Inducing Differentiation
doi 10.3389/fonc.2022.859275
- 2,279 views
- 3 citations
ORIGINAL RESEARCH
Published on 08 Apr 2022
Bruceine H Mediates EGFR-TKI Drug Persistence in NSCLC by Notch3-Dependent β-Catenin Activating FOXO3a Signaling
doi 10.3389/fonc.2022.855603
- 2,223 views
- 5 citations
ORIGINAL RESEARCH
Published on 22 Mar 2022
Gracillin Shows Potential Efficacy Against Non-Small Cell Lung Cancer Through Inhibiting the mTOR Pathway
doi 10.3389/fonc.2022.851300
- 2,785 views
- 16 citations
ORIGINAL RESEARCH
Published on 11 Mar 2022
Knockdown of AKR1C3 Promoted Sorafenib Sensitivity Through Inhibiting the Phosphorylation of AKT in Hepatocellular Carcinoma
doi 10.3389/fonc.2022.823491
- 3,576 views
- 11 citations
ORIGINAL RESEARCH
Published on 10 Mar 2022
Comparative Proteomics Analysis Reveals the Reversal Effect of Cryptotanshinone on Gefitinib-Resistant Cells in Epidermal Growth Factor Receptor-Mutant Lung Cancer
doi 10.3389/fphar.2022.837055
- 2,200 views
- 6 citations
ORIGINAL RESEARCH
Published on 03 Mar 2022
α-Hederin Inhibits the Proliferation of Hepatocellular Carcinoma Cells via Hippo-Yes-Associated Protein Signaling Pathway
doi 10.3389/fonc.2022.839603
- 2,509 views
- 15 citations
SYSTEMATIC REVIEW
Published on 01 Mar 2022
Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy
doi 10.3389/fonc.2022.834072
- 6,629 views
- 34 citations
ORIGINAL RESEARCH
Published on 22 Feb 2022
Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines
doi 10.3389/fphar.2022.837503
- 2,172 views
- 16 citations
ORIGINAL RESEARCH
Published on 18 Feb 2022
Reducing Acneiform Rash Induced by EGFR Inhibitors With Honeysuckle Therapy: A Prospective, Randomized, Controlled Study
doi 10.3389/fphar.2022.835166
- 3,690 views
- 4 citations
ORIGINAL RESEARCH
Published on 15 Feb 2022
Thymopentin-Mediated Inhibition of Cancer Stem Cell Stemness Enhances the Cytotoxic Effect of Oxaliplatin on Colon Cancer Cells
doi 10.3389/fphar.2022.779715
- 2,628 views
- 5 citations
CASE REPORT
Published on 16 Dec 2021
Triple-Regimen of Vemurafenib, Irinotecan, and Cetuximab for the Treatment of BRAFV600E-Mutant CRC: A Case Report and Review
doi 10.3389/fphar.2021.795381
- 3,042 views
- 11 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore